+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

EAACI position statement on asthma exacerbations and severe asthma



EAACI position statement on asthma exacerbations and severe asthma



Allergy 68(12): 1520-1531



Asthma exacerbations and severe asthma are linked with high morbidity, significant mortality and high treatment costs. Recurrent asthma exacerbations cause a decline in lung function and, in childhood, are linked to development of persistent asthma. This position paper, from the European Academy of Allergy and Clinical Immunology, highlights the shortcomings of current treatment guidelines for patients suffering from frequent asthma exacerbations and those with difficult-to-treat asthma and severe treatment-resistant asthma. It reviews current evidence that supports a call for increased awareness of (i) the seriousness of asthma exacerbations and (ii) the need for novel treatment strategies in specific forms of severe treatment-resistant asthma. There is strong evidence linking asthma exacerbations with viral airway infection and underlying deficiencies in innate immunity and evidence of a synergism between viral infection and allergic mechanisms in increasing risk of exacerbations. Nonadherence to prescribed medication has been identified as a common clinical problem amongst adults and children with difficult-to-control asthma. Appropriate diagnosis, assessment of adherence and other potentially modifiable factors (such as passive or active smoking, ongoing allergen exposure, psychosocial factors) have to be a priority in clinical assessment of all patients with difficult-to-control asthma. Further studies with improved designs and new diagnostic tools are needed to properly characterize (i) the pathophysiology and risk of asthma exacerbations, and (ii) the clinical and pathophysiological heterogeneity of severe asthma.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052745344

Download citation: RISBibTeXText

PMID: 24410781

DOI: 10.1111/all.12275


Related references

Impact of asthma exacerbations and asthma triggers on asthma-related quality of life in patients with severe or difficult-to-treat asthma. Journal of Allergy and Clinical Immunology. in Practice 2(5): 544, 2015

Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthma. Journal of Allergy and Clinical Immunology 124(5): 921-927, 2009

Managing asthma exacerbations in the emergency department: summary of the National Asthma Education and Prevention Program Expert Panel Report 3 guidelines for the management of asthma exacerbations. Journal of Emergency Medicine 37(2 Suppl): S6, 2009

Managing asthma exacerbations in the emergency department: summary of the National Asthma Education and Prevention Program Expert Panel Report 3 guidelines for the management of asthma exacerbations. Journal of Allergy and Clinical Immunology 124(2 Suppl): S5, 2009

Asthma control and severe exacerbations in patients with moderate or severe asthma in Jilin Province, China: a multicenter cross-sectional survey. Bmc Pulmonary Medicine 16(1): 130, 2016

Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. Journal of Allergy and Clinical Immunology 124(5): 895-902.E1-4, 2009

Guidelines for management of asthma in adults: II--Acute severe asthma. Statement by the British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign. BMJ 301(6755): 797-800, 1990

Confusing Terminology: Difficult Asthma, Difficult-to-Treat Asthma, Difficult-to-Control Asthma, Therapy-Resistant Asthma, Severe Asthma, and Refractory Asthma. Which One is Truly Severe Asthma?. Turkish Thoracic Journal 2018:, 2018

Asthma exacerbations and lung function in patients with severe or difficult-to-treat asthma. Journal of Allergy and Clinical Immunology 136(4): 1125-7.E4, 2015

Asthma control and exacerbations in patients with severe asthma treated with omalizumab in Portugal. Revista Portuguesa de Pneumologia 2015:, 2015

Asthma Exacerbations Associated with Lung Function Decline in Patients with Severe Eosinophilic Asthma. Journal of Allergy and Clinical Immunology. in Practice 6(3): 980-986.E1, 2018

EAACI consensus statement for investigation of work-related asthma in non-specialized centres. Allergy 67(4): 491-501, 2012

Asthma exacerbations. 5: assessment and management of severe asthma in adults in hospital. Thorax 62(5): 447-458, 2007

Predictors of severe exacerbations, poor asthma control, and β-agonist overuse for patients with asthma. Journal of Allergy and Clinical Immunology. in Practice 2(6): 751-758, 2015

Comparison of asthma exacerbations in pediatric and adult patients with severe or difficult-to-treat asthma. Journal of Allergy and Clinical Immunology 124(5): 1106-1108, 2009